NYSE:ENVA
Related posts
Nervous markets await NvidiaThis summary was created by AI, based on 1 opinions in the last 12 months.
Enova International (ENVA-N) has garnered reviews that highlight its unconventional approach to lending, which may be perceived as too risky for some investors. This unique business model positions the company distinctly within the financial services sector but also raises concerns about the associated risks. While some experts may appreciate the innovative strategies employed by Enova, others urge caution, suggesting that the potential rewards may not outweigh the risks involved. Overall, the reviews indicate a divergence of opinion, with the unconventional lending practices leaving a mixed impression among analysts. As a result, prospective investors should weigh these factors carefully before considering any investment in Enova International.
Enova International is a American stock, trading under the symbol ENVA-N on the New York Stock Exchange (ENVA). It is usually referred to as NYSE:ENVA or ENVA-N
In the last year, 2 stock analysts published opinions about ENVA-N. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Enova International.
Enova International was recommended as a Top Pick by on . Read the latest stock experts ratings for Enova International.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Enova International published on Stockchase.
On 2025-08-05, Enova International (ENVA-N) stock closed at a price of $103.88.
ENVA provides consumer credit services in the US and Brazil. Recently reported earnings showed a 28% increase in originations and 48% increase in EPS. Cash reserves are growing, partially thru increased debt and shares are being bought back. It trades at 11x earnings, 2.1x book and supports a ROE of 21%. We recommend setting a stop-loss at $77, looking to achieve $131 -- upside potential of 25%. Yield 0%
(Analysts’ price target is $131.12)